Ping Min

Title: The Innovative Contributions of Ping Min

Introduction

Ping Min is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on the development of compounds with potential medical applications, particularly in the inhibition of HIF prolyl hydroxylase and the promotion of endogenous EPO generation.

Latest Patents

Ping Min's latest patents include a compound of 3-hydroxyl pyridine, along with its preparation method and pharmaceutical uses. This compound is represented by a specific formula, where various groups can be independently selected. The patent also details a method for preparing the compound and its use in pharmaceutical compositions aimed at treating specific medical conditions. Another significant patent involves a compound of 5-hydroxyl-1,7-naphthyridine, which is substituted by aryloxy or heteroaryloxy. This patent outlines the preparation method and pharmaceutical applications of the compound, emphasizing its potential in medicine.

Career Highlights

Ping Min is currently associated with Shenyang Sunshine Pharmaceutical Co. Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a strong focus on developing new compounds that can lead to effective medical treatments.

Collaborations

Ping Min collaborates with talented individuals in his field, including coworkers Yunlong Zhou and Suixiong Cai. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Ping Min's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of chemistry and its applications in medicine, paving the way for future developments in the field.